These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33790458)

  • 1. The future of sex in elite sport.
    Photopoulos J
    Nature; 2021 Apr; 592(7852):S12-S15. PubMed ID: 33790458
    [No Abstract]   [Full Text] [Related]  

  • 2. Out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes.
    Karkazis K; Jordan-Young R; Davis G; Camporesi S
    Am J Bioeth; 2012; 12(7):3-16. PubMed ID: 22694023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the new policies on hyperandrogenism in elite female athletes really out of bounds? Response to "out of bounds? A critique of the new policies on hyperandrogenism in elite female athletes".
    Bermon S; Ritzén M; Hirschberg AL; Murray TH
    Am J Bioeth; 2013; 13(5):63-5. PubMed ID: 23557056
    [No Abstract]   [Full Text] [Related]  

  • 4. Gender transports: privileging the "natural" in gender testing debates for intersex and transgender athletes.
    Wahlert L; Fiester A
    Am J Bioeth; 2012; 12(7):19-21. PubMed ID: 22694025
    [No Abstract]   [Full Text] [Related]  

  • 5. The new policy on hyperandrogenism in elite female athletes is not about "sex testing".
    Sánchez FJ; Martínez-Patiño MJ; Vilain E
    J Sex Res; 2013; 50(2):112-5. PubMed ID: 23320653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sport, sex segregation, and sex testing: critical reflections on this unjust marriage.
    Dworkin SL; Cooky C
    Am J Bioeth; 2012; 12(7):21-3. PubMed ID: 22694026
    [No Abstract]   [Full Text] [Related]  

  • 7. Reexamining rationales of "fairness": an athlete and insider's perspective on the new policies on hyperandrogenism in elite female athletes.
    Viloria HP; Martínez-Patino MJ
    Am J Bioeth; 2012; 12(7):17-9. PubMed ID: 22694024
    [No Abstract]   [Full Text] [Related]  

  • 8. The complexities of sport, gender, and drug testing.
    Sailors PR; Teetzel SJ; Weaving C
    Am J Bioeth; 2012; 12(7):23-5. PubMed ID: 22694027
    [No Abstract]   [Full Text] [Related]  

  • 9. Large divergence in testosterone concentrations between men and women: Frame of reference for elite athletes in sex-specific competition in sports, a narrative review.
    Clark RV; Wald JA; Swerdloff RS; Wang C; Wu FCW; Bowers LD; Matsumoto AM
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):15-22. PubMed ID: 30136295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sport is arbitrary, and that's ok.
    O'Connor D; Dasgupta I
    Am J Bioeth; 2012; 12(7):30-1. PubMed ID: 22694030
    [No Abstract]   [Full Text] [Related]  

  • 11. Getting a leg up on the competition: the importance of osteology in elite athletics.
    Sutherland MB; Langer B; Wassersug R
    Am J Bioeth; 2012; 12(7):25-7. PubMed ID: 22694028
    [No Abstract]   [Full Text] [Related]  

  • 12. The limits of acceptable biological variation in elite athletes: should sex ambiguity be treated differently from other advantageous genetic traits?
    Bostwick JM; Joyner MJ
    Mayo Clin Proc; 2012 Jun; 87(6):508-13. PubMed ID: 22677070
    [No Abstract]   [Full Text] [Related]  

  • 13. New standards, same refrain: the IAAF's regulations on hyperandrogenism.
    Schultz J
    Am J Bioeth; 2012; 12(7):32-3. PubMed ID: 22694031
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperandrogenism and intersex controversies in women's olympics.
    Xavier NA; McGill JB
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3902-7. PubMed ID: 22990091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical and ethical concerns regarding women with hyperandrogenism and elite sport.
    Sonksen P; Ferguson-Smith MA; Bavington LD; Holt RI; Cowan DA; Catlin DH; Kidd B; Davis G; Davis P; Edwards L; Tamar-Mattis A
    J Clin Endocrinol Metab; 2015 Mar; 100(3):825-7. PubMed ID: 25587808
    [No Abstract]   [Full Text] [Related]  

  • 16. Intersex and the Olympic Games.
    Ritchie R; Reynard J; Lewis T
    J R Soc Med; 2008 Aug; 101(8):395-9. PubMed ID: 18687862
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism.
    Fénichel P; Paris F; Philibert P; Hiéronimus S; Gaspari L; Kurzenne JY; Chevallier P; Bermon S; Chevalier N; Sultan C
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1055-9. PubMed ID: 23633205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgender Policy in Sport, A Review of Current Policy and Commentary of the Challenges of Policy Creation.
    Ingram BJ; Thomas CL
    Curr Sports Med Rep; 2019 Jun; 18(6):239-247. PubMed ID: 31385840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Harrison Bergeron olympics.
    Karkazis K; Jordan-Young R
    Am J Bioeth; 2013; 13(5):66-9. PubMed ID: 23557057
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural selection for genetic variants in sport: the role of Y chromosome genes in elite female athletes with 46,XY DSD.
    Ferguson-Smith MA; Bavington LD
    Sports Med; 2014 Dec; 44(12):1629-34. PubMed ID: 25160863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.